Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BioInvent International has signed an agreement with Alligator Bioscience AB to provide process development and manufacturing services for Alligator’s new bispecific antibody, ADC-1015.
read more
Wednesday, December 13, 2017
Science Exchange announced a partnership with Bioinformatics Solutions to offer online access to its protein de novo sequencing services to scientists around the globe.
read more
Biognosys, a provider of proteomics solutions for drug discovery and development, announced the operational readiness of its new proteomics facility in Massachusetts.
read more
Thursday, January 05, 2023
Biognosys AG and Bruker Corporation announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not disclosed.
read more
Monday, November 27, 2017
Biogen and Alkermes announced they have entered into a global license and collaboration agreement to develop and commercialize ALKS 8700.
read more
Fujifilm will acquire the shares of Biogen’s subsidiary, which holds Biogen’s biologics manufacturing operations in Hillerød, Denmark.
read more
Biofrontera has entered into an agreement to acquire all shares in Cutanea Life Sciences through its subsidiary Biofrontera Newderm LLC as the acquirer, with Maruho Co., Ltd., Japan as the seller.
read more
Thursday, January 09, 2025
Biofidelity and CellCarta announced a strategic partnership agreement to utilize Biofidelity’s Aspyre® Lung in global clinical trials. Aspyre Lung simplifies the detection of established non-small cell lung cancer (NSCLC) biomarkers by analyzing both...
read more
Thursday, January 16, 2025
Biofidelity, and CellCarta announced a strategic partnership agreement to utilize Biofidelity’s Aspyre® Lung in global clinical trials.
read more
Thursday, October 03, 2024
BioDuro-Sundia, a global contract research, development, and manufacturing organization (CRDMO), announced the launch of a new Compound Management Center at its Waigaoqiao site in the Shanghai Free-Trade Zone, China. This new center enables the ...
read more
Tuesday, December 03, 2024
BioDuro-Sundia, a contract research, development, and manufacturing organization, announced the appointment of Alan Findlater as Chief Commercial Officer.
read more
BioDuro, A PPD® Company, today announced it has opened a new state-of-the-art laboratory in Shanghai, strengthening its ability to provide biopharmaceutical clients an extensive range of customized drug discovery services in Asia Pacific. The new lab...
read more
Thursday, November 12, 2015
BioDuro, a global CRO focused on preclinical chemistry, biology, and fully outsourced integrated drug development services for pharmaceutical partners, announced the merger of its US operations with Formex, LLC, a provider of pharmaceutical API ...
read more
Tuesday, October 09, 2018
BioDuro has established a new drug discovery center for chemistry and biology in San Diego, CA.
read more
BioDuro has broadly launched new antibody- and cell-based therapy discovery services.
read more